Introduction
Method
Study setting
Quality of life at 30 days and 12 months
Clinical presentations
Statistical analysis
Results
Baseline and procedural characteristics
Total (n = 866) | Women (n = 278) | Men (n = 588) | P* | |
---|---|---|---|---|
Age (years), mean ± SD | 67.60 ± 9.82 | 70.00 ± 9.03 | 66.46 ± 9.98 | < 0.001 |
Low-incomea | 648 (73.5) | 235 (84.5) | 413 (70.2) | < 0.001 |
Lower educationb | 521 (59.1) | 181 (65.1) | 340 (57.8) | 0.041 |
BMI (kg/m2), mean ± SD | 22.24 ± 2.93 | 21.96 ± 3.09 | 22.37 ± 2.85 | 0.056 |
Presentation | ||||
STEMI | 114 (12.9) | 27 (9.7) | 87 (14.8) | 0.039 |
NSTEMI | 136 (15.4) | 47 (16.9) | 89 (15.1) | 0.504 |
Unstable angina | 214 (24.3) | 74 (26.6) | 140 (23.8) | 0.371 |
ACS | 464 (52.6) | 148 (53.2) | 316 (53.7) | 0.890 |
Stable CAD | 402 (45.6) | 130 (46.8) | 272 (46.3) | |
Medical history | ||||
Hypertension | 578 (65.5) | 208 (74.8) | 370 (62.9) | 0.001 |
Diabetes mellitus | 238 (27.0) | 94 (33.8) | 144 (24.5) | 0.004 |
Hyperlipidaemia | 270 (30.6) | 106 (38.1) | 164 (27.9) | 0.002 |
Prior cerebral vascular disease | 121 (13.7) | 38 (13.7) | 83 (14.1) | 0.860 |
Current smoking | 108 (12.2) | 1 (33.3) | 107 (25.6) | 0.760 |
Previous CABG | 11 (1.2) | 0 (0.0) | 11 (1.9) | 0.022 |
Previous PCI | 309 (35.0) | 80 (28.8) | 229 (38.9) | 0.004 |
Tests prior to PCI | ||||
Left ventricular ejection fraction ≤ 40% | 86 (9.8) | 24 (9.4) | 62 (12.0) | 0.292 |
Moderate to severe renal impairment a | 15 (1.7) | 3 (1.1) | 12 (2.1) | 0.311 |
Procedural characteristics | ||||
Radial access | 685 (77.7) | 220 (79.1) | 465 (79.1) | 0.985 |
Left main disease | 93 (10.5) | 17 (6.1) | 76 (12.9) | 0.003 |
Lesion type B2 and C | 822 (93.2) | 263 (94.6) | 559 (95.1) | 0.772 |
≥ 2 Stents per lesion | 359 (40.7) | 105 (37.8) | 254 (43.2) | 0.130 |
PCI with ≥ 2 lesions | 182 (20.6) | 57 (20.5) | 125 (21.3) | 0.799 |
Stent used | 856 (97.1) | 276 (99.3) | 580 (98.6) | 0.410 |
Balloon used only | 3 (0.3) | 1 (0.4) | 2 (0.3) | 0.963 |
Procedural success | 860 (97.5) | 277 (99.6) | 583 (99.1) | 0.416 |
In hospital major bleeding | 15 (1.7) | 8 (2.9) | 7 (1.2) | 0.076 |
30 days and 12 months quality of life post PCI
Variable | Total, n (%) | Women, n (%) | Men, n (%) | Crude | Adjustedb | ||
---|---|---|---|---|---|---|---|
OR (95% CI)a | P value* | OR (95% CI) | P value* | ||||
HRQoL mobility | |||||||
No problem | 731 (84.4) | 216 (77.7) | 515 (87.6) | 1.00 (reference) | 1.00 (reference) | ||
Some problem | 128 (14.8) | 60 (21.6) | 68 (11.6) | 2.025 (1.393–2.943) | < .001 | 1.818 (1.218–2.713) | 0.003 |
Unable to walk around | 7 (0.8) | 2 (0.7) | 5 (0.9) | ||||
HRQoL personal care | |||||||
No problem | 778 (89.9) | 238 (85.6) | 540 (91.8) | 1.00 (reference) | 1.00 (reference) | ||
Some problem | 76 (8.8) | 35 (12.6) | 41 (7.0) | 1.891 (1.210–2.955) | 0.005 | 1.590 (0.987–2.563) | 0.057 |
Unable to wash/dress self | 12 (1.4) | 5 (1.8) | 7 (1.2) | ||||
HRQoL usual activity | |||||||
No problem | 179 (20.7) | 48 (17.3) | 131 (22.3) | 1.00 (reference) | 1.00 (reference) | ||
Some problem | 667 (77.0) | 221 (79.5) | 446 (75.9) | 1.374 (0.952–1.982) | 0.09 | 1.193 (0.807–1.764) | 0.377 |
Unable to perform usual activities | 20 (2.3) | 9 (3.2) | 11 (1.9) | ||||
HRQoL pain/discomfort | |||||||
No pain/discomfort | 128 (14.8) | 31 (11.2) | 97 (16.5) | 1.00 (reference) | 1.00 (reference) | ||
Mod pain/discomfort | 696 (80.4) | 227 (81.7) | 469 (79.8) | 1.574 (1.022–2.425) | 0.04 | 1.360 (0.860–2.153) | 0.189 |
Extreme pain/discomfort | 42 (4.8) | 20 (7.2) | 22 (3.7) | ||||
HRQoL anxiety/depression | |||||||
No anxiety/depression | 729 (84.2) | 228 (82.0) | 501 (85.2) | 1.00 (reference) | 1.00 (reference) | ||
Mod anxiety/depression | 132 (15.2) | 50 (18.0) | 82 (13.9) | 1.263 (0.862–1.849) | 0.23 | 1.180 (0.786–1.772) | 0.424 |
Extreme anxiety/depression | 5 (0.6) | 0 (0.0) | 5 (0.9) | ||||
HRQoL EQ-5D Index Score, geometric means (95% CI) | |||||||
Crude | 0.780 (0.770–0.790) | 0.755 (0.738–0.773) | 0.792 (0.779–0.805) | 0.001 | |||
Adjustedb | NA | 0.763 (0.744–0.781) | 0.788 (0.775–0.801) | 0.031 | |||
HRQoL own health state today (VAS), means (95% CI) | |||||||
Crude | 69.69 (68.08–69.31) | 68.26 (67.24–69.27) | 69.77 (69.07–70.47) | 0.016 | |||
Adjustedb | NA | 68.64 (67.60–69.67) | 69.59 (68.89–70.28) | 0.144 | |||
Effect size | Cohen’s d: 0.175 | ε2: 0.001 |
Variable | Total, n (%) | Women, n (%) | Men, n (%) | Crude | Adjustedb | ||
---|---|---|---|---|---|---|---|
OR (95% CI)a | P value* | OR (95% CI) | P value* | ||||
HRQoL mobility | |||||||
No problem | 731 (84.4) | 232 (83.5) | 499 (84.9) | 1.112 (0.754–1.639) | 0.593 | 0.95 (0.63–1.44) | 0.820 |
Some problem | 132 (15.2) | 45 (16.2) | 87 (14.8) | ||||
Unable to walk around | 3 (0.3) | 1 (0.4) | 2 (0.3) | ||||
HRQoL personal care | |||||||
No problem | 840 (97.0) | 266 (95.7) | 574 (97.6) | 1.850 (0.844–4.054) | 0.124 | 1.48 (0.63–3.47) | 0.374 |
Some problem | 23 (2.7) | 11 (4.0) | 12 (2.0) | ||||
Unable to wash/dress self | 3 (0.3) | 1 (0.4) | 2 (0.3) | ||||
HRQoL usual activity | |||||||
No problem | 705 (81.4) | 217 (78.1) | 488 (83.0) | 1.372 (0.961–1.959) | 0.082 | 1.48 (1.01–2.16) | 0.046 |
Some problem | 157 (18.1) | 60 (21.6) | 97 (16.5) | ||||
Unable to perform usual activities | 4 (0.5) | 1 (0.4) | 3 (0.5) | ||||
HRQoL pain/discomfort | |||||||
No pain/discomfort | 570 (65.8) | 172 (61.9) | 398 (67.7) | 1.219 (0.959–1.738) | 0.092 | 1.30 (0.94–1.78) | 0.109 |
Mod pain/discomfort | 282 (32.6) | 100 (36.0) | 182 (31.0) | ||||
Extreme pain/discomfort | 14 (1.6) | 6 (2.2) | 8 (1.4) | ||||
HRQoL anxiety/depression | |||||||
No anxiety/depression | 833 (96.2) | 266 (95.7) | 567 (96.4) | 1.218 (0.590–2.513) | 0.593 | 1.29 (0.60–2.78) | 0.513 |
Mod anxiety/depression | 33 (3.8) | 12 (4.3) | 21 (3.6) | ||||
Extreme anxiety/depression | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||||
HRQoL EQ-5D Index Score, geometric means (95% CI) | |||||||
Crude | 0.866 (0.857–0.874) | 0.856 (0.841–0.871) | 0.870 (0.860–0.881) | 0.12 | |||
Adjustedb | NA | 0.859 (0.844–0.874) | 0.869 (0.859–0.879) | 0.316 | |||
HRQoL own health state today (VAS), means (95% CI) | |||||||
Crude | 72.49 (71.66–73.33) | 70.77 (69.30–72.23) | 73.31 (72.30–74.32) | 0.005 | |||
Adjustedb | NA | 71.34 (69.83–72.85) | 73.04 (72.02–74.06) | 0.074 | |||
Effect size | Cohen’s d: 0.204 | ε2: 0.003 |